Real-time enrollment status for this germline mutation clinical trial
Current Status
Recruiting
Checked: July 21, 2026 at 10:47 AM UTC
| NCT Number | NCT07019155 |
| Recruiting Status | Recruiting |
| Condition | Germline Mutation |
| Phase | Clinical Trial |
| Target Enrollment | 510 participants |
| Active Locations | 1 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | July 6, 2026 (2 weeks ago) |
As of July 21, 2026: Clinical trial NCT07019155 is currently recruiting participants. This clinical trial study for germline mutation is actively seeking new participants at 1 location across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07019155 is actively recruiting participants as of July 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07019155 was last updated 2 weeks ago (July 6, 2026). HelloStudys verifies this status automatically.